Aurobindo Pharma Q4 net up 2% to ₹921 cr

Aurobindo Pharma Q4 net up 2% to ₹921 cr thumbnail

The company said its European business crossed €1 billion in revenues during the fiscal

LEAVE A REPLY

Your email address will not be published. Required fields are marked *